Luciferase of Pyrocoelia matsumurai firefly with higher luminous intensity.
![]() Drawn by SnapGene® software |
|
| Clone info. | Luciferase of Pyrocoelia matsumurai firefly with higher luminous intensity. pPmatLuc1 is not expression vector. When the luciferase is expressed in any cells, the cDNA must be transferred to appropriate expression vectors by your own. |
|---|---|
| Vector backbone | pUC19 (Plasmid) |
| Size of vector backbone | 2.7 kb |
| Selectable markers | Amp^r |
| Growth conditions | LB+Amp, 37oC |
| Gene/insert name | Pyrocoelia matsumurai Luciferase cDNA |
| Depositor|Developer | OLYMPUS CORPORATION, | Ogoh, Katsunori | |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
| Ordering forms | Order form [Credit Card Payment MTA, for use for not-for-profit academic purpose [Word MTA, for use for for-profit purpose [Word Please visit Information of Request for Distribution.[link] |
|---|---|
| Terms and conditions for distribution | In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of the literature designated by the DEPOSITOR is requested (Akiyoshi R, Ogoh K, Suzuki H. 2012. Firefly luciferase. Japan patent publication 2012-235756). RECIPIENT must contact the OLYMPUS CORPORATION in the case of application for any patents or commercial use(*) based on the results from the use of the BIOLOGICAL RESOURCE. (*)Commercial use shall include: (1) incorporation of the BIOLOGICAL RESOURCE into products for sale; (2) the use of to the BIOLOGICAL RESOURCE for screening candidate compounds; (3) the use of to the BIOLOGICAL RESOURCE for quality control. The RECIPIENT of any organization including for-profit or nonprofit organizations may intend to use the BIOLOGICAL RESOURCE for basic researches with such purposes. |
[open/close]| 必要書類 | 提供依頼書 提供同意書 (MTA, 非営利学術目的用)[Word 提供同意書 (MTA, 営利目的用)[Word 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
|---|---|
| MTAに書く使用条件 | 利用者は、研究成果の公表にあたって別紙に定める寄託者の指定する文献を引用する (ホタル由来ルシフェラーゼ 特開2012-235756)。利用者が本件リソースを使用して得られた研究成果に基づき特許等の申請、及び商業活動(*)を行う場合は、オリンパス株式会社と別途協議を行う。(*)商用活動とは,本件リソースが製品の一部に組み込まれる場合,本件リソースを利用して製品となる候補物を探索または製品の品質管理を行う場合等とする。そのための基礎検討の使用に関しては,営利,非営利機関等の利用者制限は定めない。 |
| Catalog # | Resource name | Shipping form | Fee |
|---|---|---|---|
| RDB14359 | pPmatLuc1 | DNA solution |
Materials & Methods section:
| The pPmatLuc1 was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB14359). |
Reference section:
| Ogoh, K., Akiyoshi, R., Suzuki, H., Cloning and mutagenetic modification of the firefly luciferase gene and its use for bioluminescence microscopy of engrailed expression during Drosophila metamorphosis. Biochem. Biophys. Rep. 23: 100771 (2020). PMID 32490216. [PubMed] [Article] [RRC of NBRP] |
| Akiyoshi, R., Ogoh, K., Suzuki, H., Firefly luciferase. Japan Patent Abstracts 2012-235756. [RRC of NBRP] |
Further references such as user reports and related articles (go to bottom)
Original, user report and related articles
| original | Ogoh, K., Cloning and mutagenetic modification of the firefly luciferase gene and its use for bioluminescence microscopy of engrailed expression during Drosophila metamorphosis. Biochem. Biophys. Rep. 23: 100771 (2020). PMID 32490216. [PubMed] [Article] [RRC of NBRP] |
|---|---|
| original | Akiyoshi, R., Firefly luciferase. Japan Patent Abstracts 2012-235756. [RRC of NBRP] |
| reference | Nakashiba, T., Development of two mouse strains conditionally expressing bright luciferases with distinct emission spectra as new tools for in vivo imaging. Lab. Anim. (NY) 52 (10): 247-257 (2023). PMID 37679611. [PubMed] [Article] [RRC of NBRP] |
| review | Suzuki, H., Bioluminescence microscopy for the visualization of gene expression patterns and the study of embryonic development. Proc. Arthropod. Embryol. Soc. Jpn. 53: 1-7 (2021). |
| user_report | Yamamoto, K., In vivo imaging identified efficient antimicrobial treatment against Mycobacterium marinum infection in mouse footpads. Sci. Rep. 14 (1): 24343 (2024). PMID 39420066. [PubMed] [Article] [RRC of NBRP] |
Featured content